Recently, the platinum-based chemotherapeutics, cisplatin, and carboplatin have been found to accumulate in cancer cells via the LRRC8A/LRRC8D-containing heteromers, which were downregulated with the development of chemoresistance (28, 29). The gene discussed is LRRC8A; the disease is cancer.